Zydus Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1,362.00 Cr
- Paid Up Capital ₹ 21.62 Cr
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 302.98 Cr
- Satisfied Charges ₹ 225.00 Cr
- Revenue Growth 9.27%
- Profit Growth 207.50%
- Ebitda 17.15%
- Net Worth -6.35%
- Total Assets -4.73%
About Zydus Healthcare
Zydus Healthcare Limited (ZHL) is a leading Public Limited Indian Non-Government Company incorporated in India on 02 August 1989 and has a history of 35 years and six months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as German Remedies Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1,362.00 Cr and a paid-up capital of Rs 21.62 Cr.
The company currently has active open charges totaling ₹302.98 Cr. The company has closed loans amounting to ₹225.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zydus Healthcare Limited India are Arvind Bothra as CFO and Sanjay Gupta as Company Secretary. Harish Sadana, Bhadresh Shah, Nitinkumar Parekh, and Three other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51900GJ1989PLC079501
- Company No.
079501
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Aug 1989
- Date of AGM
05 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Zydus Healthcare Limited offer?
Zydus Healthcare Limited offers a wide range of products and services, including Common Disease Medicines, Skin Ointment, Brain & Nervous System Drugs, Antiepileptic Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Allopathic Cough Syrup, Anti Cancer Injection, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Zydus Healthcare?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harish Sadana ![]() | Managing Director | 01-Jul-2021 | Current |
Arvind Bothra | CFO | 25-May-2023 | Current |
Sanjay Gupta | Company Secretary | 01-Sep-2016 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sharvil Patel ![]() | Director | 01-Sep-2016 | Current |
Nitinkumar Parekh ![]() | Director | 30-Jun-2011 | Current |
Bhadresh Shah ![]() | Additional Director | 05-Aug-2024 | Current |
Bhavana Doshi ![]() | Director | 01-Sep-2016 | Current |
Deevyesh Radia ![]() | Director | 01-Sep-2016 | Current |
Financial Performance of Zydus Healthcare.
Zydus Healthcare Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.27% increase. The company also saw a substantial improvement in profitability, with a 207.5% increase in profit. The company's net worth dipped by a decrease of 6.35%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Zydus Healthcare?
In 2023, Zydus Healthcare had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹302.98 Cr
₹225.00 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 300.00 Cr
- State Bank Of India : 2.43 Cr
- The British Of The Middile East : 0.55 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Dec 2016 | Hdfc Bank Limited | ₹300.00 Cr | Open |
10 Apr 1991 | The British Of The Middile East | ₹5.50 M | Open |
04 Apr 1990 | State Bank Of India | ₹2.43 Cr | Open |
30 Jul 2018 | Citi Bank N.A. | ₹225.00 Cr | Satisfied |
How Many Employees Work at Zydus Healthcare?
Zydus Healthcare has a workforce of 8433 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zydus Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Healthcare's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.